Differences in the contents of sixteen bioactive components (three tannins, five anthraquinones, six flavonoids and two neolignans) between Da-Cheng-Qi decoction (DCQD) and its three constitutional herbal medicines (Radix et Rhizoma Rhei, Cortex Magnoliae officinalis, and Fructus Aurantii Immaturus) were compared using validated HPLC/DAD methods. The results indicated that there existed some kinds of interactions between these constitutional natural medicines during the DCQD preparation procedure, which could either enhance or depress the extractive rates of bioactive components.
Described in Shang-Han-Lun (Treatise on Cold Damage Diseases, a Chinese medicine classic from the Han dynasty), Da-Cheng-Qi decoction (DCQD) is a well known purgative formula consisting of four natural medicines [Radix et Rhizoma Rhei (Dahuang), Cortex Magnoliae officinalis (Houpu), Fructus Aurantii Immaturus (Zhishi) and Natrii Sulfas (Mangxiao)] [1] . Nowadays, DCQD is usually used to treat acute intestinal obstruction, acute cholecystitis and appendicitis [2] , post-traumatic respiratory distress syndrome [3] , reducing acute-phase protein levels in patients with multiple organ failure syndromes [4] , and relieving inflammation in patients after a tumor operation [5] . Recently DCQD was found to possess anti-inflammatory effects apart from its purgative activities [6] . Besides the above mentioned clinical uses in humans, DCQD is also a traditional veterinary drug recommended by the Chinese Veterinary Pharmacopoeia (CYP) and widely used for the treatment of animal diseases [7] [8] [9] [10] .
In previous studies, we have identified the flavanone 7glycoside isomers in DCQD using a semi-MS n method [11] and explored the pharmacokinetic profiles of its several major bioactive components in rats [12, 13] . In this work, the aim was to compare the contents differences of major bioactive components between DCQD and its constitutional herbal medicines using HPLC/DAD. Sixteen bioactive components from three herbs (Table  1S , supporting information) were chosen as chemical markers to perform this experiment: Rhein, emodin, chrysophanol, aloe-emodin and physcion are major active anthraquinones from Radix et Rhizoma Rhei; (+)-catechin, (-)-epicatechin and gallic acid are representative tannins from Radix et Rhizoma Rhei; and hesperidin, naringin, neohesperidin, naringenin, hesperetin and nobiletin are major flavonoids from Fructus Aurantii Immaturus; and magnolol and honokiol are neolignans present in Cortex Magnoliae officinalis. As their polarity properties are very different, in order to obtain good separation with a short analysis time, the sixteen selected bioactive components were divided into two groups according to their structure type and elution sequence. (+)-Catechin, (-)-epicatechin and gallic acid are water soluble with a short retention time on a C 18 column; these were NPC Natural Product Communications 2010 Vol. 5 No. 6 893 -896 quantified using gradient program I. The other thirteen components were analyzed using gradient program II ( Table 1) . No interference was found with the retention time of any of the components ( Figure 1S -3S, supporting information). The UV spectral purity tests and blank sample analysis confirmed that no impurities co-eluted with the components determined. aloe-emodin, chrysophanol, and physcion, respectively. The lower limits of detection (LOD) for (+)-catechin, (-)-epicatechin, gallic acid, rhein, physcion, emodin, aloe-emodin, chrysophanol, nobiletin, naringin, neohesperidin, hesperidin, naringenin, hesperetin, magnolol and honokiol were 1.5, 1.5, 1.5, 0.6, 0.3, 0.3, 0.3, 0.3, 0.6, 0.5, 0.5, 0.5, 0.3, 0.3, 0.5 and 0.3, respectively. Table 2S (supporting information) gives the inter-and intra-day variations and recovery results. The overall inter-and intra-day, and repeatability variations were 0.29-2.97% and 0.41-2.98%, respectively. The results of recovery tests indicated that the methods developed were accurate enough for the determination of the 16 bioactive components in DCQD. As demonstrated in Table 3S (supporting information), the results show high stability within 24 h and the good repeatability of the method.
The developed and validated HPLC/DAD methods were successfully applied to determine the sixteen components in DCQD, single herb decoctions (positive control), and a single natural medicinefree decoction (negative control). Table 2 summarizes the mean concentrations results of these sixteen bioactive components. In order to obtain a more intuitional impression of the content differences of the sixteen bioactive components between DCQD and its (Table 3) show that there exist some kinds of interactions between the four constitutional natural medicines in DCQD, which influence the extractive rates of the bioactive components during the preparation procedure. These influences are quite different for different types of components. The contents of naringin and neohesperidin are very close between single Fructus Aurantii Immaturus decoction, DCQD and the single drug free decoction of the three other natural medicines, while the contents of their aglycones (naringenin and hesperetin) are much higher in single Fructus Aurantii Immaturus than those in DCQD and the single drug-free decoction of the other three natural medicines, which suggest that the three other natural medicines could inhibit the extraction of flavonone aglycones significantly when the four natural medicines were codecocted. The enhancement effect of Natrii Sulfas and Cortex Magnoliae officinalis on the extractive rate of gallic acid was offset by the inhibition effect of Fructus Aurantii Immaturus, so the relative concentration of aloe-emodin, chrysophanol and physcion), but Natrii Sulfas could inhibit the extraction of emodin and chrysophanol, but enhance those of rhein, aloe-emodin, and physcion.
The above results demonstrate that some drug-drug interactions exist, such as enhancement and depression of extractive rate of the bioactive components in DCQD during the preparation procedure. Thus, when DCQD is used for disease treatment, the relative proportions of its four constitutional medicines should be fixed or else unexpected side effects may result due to the change of bioactive component contents.
Experimental
Full details about reagents, reference standards, natural medicines, preparation of Da-Cheng-Qi decoction, single natural medicine decoctions and single natural medicine-free decoction have been published by us previously [15] .
Instrumentation
and operation conditions: HPLC/DAD analysis was performed on an Agilent Series 1100 liquid chromatograph (Agilent Technologies, Palo Alto, CA, USA), equipped with a quadruple pump and a DAD detector. Data were acquired and processed by HP ChemStation software. Chromatography was carried out on an Aglient Zorbax SB-C18 column (5μ, 250 mm × 4.6 mm) with the detection wavelength at 275 nm. UV spectra were stored from 200 nm to 400 nm. Flow rate was set at 1.0 mL/min and 20 µL samples were injected. Methanol: acetonitrile: water (0.2% formic acid) was used as mobile phase. Two gradient elution programs were utilized: (+)-catechin, (-)-epicatechin and gallic acid were quantified using elution program I, and the other 13 components with elution program II (Table 1 ).
Method validation:
The two developed HPLC/UV methods were validated in terms of specificity, recovery, linearity, accuracy, precision and repeatability. Three concentration levels for the 16 chemical markers were involved (10, 50, 200 μg/mL for (+)-catechin, (-)-epicatechin and gallic acid; 5, 20, 100 μg/mL for rhein and nobiletin; 25, 125, 500 μg/mL for naringin and neohesperidin; 3, 15, 75 μg/mL for hesperidin and magnolol; 2.5, 12.5, 50 μg/mL for honokiol, naringenin, hesperetin, emodin, aloe-emodin, chrysophanol and physcion, respectively). The method specificity was tested by comparing the chromatograms of blank solvent, DCQD, single drug decoction and single drug free decoction.
The calibration curves were constructed by analyzing 7 different concentrations of standard solutions, and then the regression equations were calculated in the form of C = bA + a, where A and C were peak area and sample concentrations. The calibration curve points equivalent to 5, 10, 20, 50, 100, 200 μg/mL for (+)-catechin, (-)-epicatechin, and gallic acid; 2, 5, 10, 20, 50, 100, 200 μg/mL for rhein and nobiletin; 12.5, 25, 50, 125, 250, 500, 1000 μg/mL for naringin and neohesperidin; 1.5, 3, 7.5, 15, 30, 75, 150 μg/mL for hesperidin and magnolol; 1, 2.5, 5, 12.5, 25, 50, 100 μg/mL for honokiol, naringenin, hesperetin, emodin, aloe-emodin, chrysophanol, and physcion.
The limits of detection (LOD) and quantification (LOQ) under the present chromatographic conditions were determined at a signal-to-noise ratio (S/N) of 3 and 10, respectively.
Intra-day and inter-day variations were determined by assaying standard solutions at the 3 different concentrations of each standard. The intra-day variation was determined by analyzing the 5 replicates on the same day and inter-day variation was determined on 5 consecutive days. The R.S.D. was taken as a measure of precision.
To confirm the repeatability, 6 parallel DCQD samples were prepared and analyzed. The R.S.D. was taken as the measures of precision and accuracy of repeatability test.
Recovery tests were carried out by spiking known contents of standard samples into a DCQD sample and comparing the determined amount of these standards with the amount originally added. The average recoveries were determined from the formula: recovery (%) = (amount found -original amount)/amount spiked×100%, and RSD (%) = (SD/mean) ×100%.
Stability was tested with a DCQD and analyzed at 0 and 24 h. The peak area ratio of each component detected at 24 and 0 h was taken as the measure of stability.
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